Translational Research & Pharmacology Core Facility

Director: John J. Pink, PhD
Assistant Professor, General Medical Sciences (Oncology)
john.pink@case.edu

Co-Director (Pharmacology): Yan Xu, PhD
Professor, Chemistry
yan.xu@case.edu

CCF Site Director: Daniel J. Lindner, MD, PhD
Assistant Professor, Cancer Biology
lindned@ccf.org

Operations Director: Paul Hartman, MS
Manager of Dahms Clinical Research Unit Core Lab
phh@case.edu

  Translational Group Hohler

Services and Technologies

List of Services

  1. Consultation (protocol, correlate, LOI, SOP, budget development)
  2. Sample informatics and correlate data (databases)
  3. Data analysis
  4. Sample handling (receiving, storage, distribution)
  5. Sample Processing (whole blood and paraffin block processing
    1. Dispensing whole blood aliquots
    2. Routine Blood Processing (PBMC, serum, or plasma isolation)
    3. DNA, RNA, protein extraction
    4. Flow or laser scanning cytometry staining
  6. Lab Analysis
    1. Western Blots
    2. Standard ELISAs (Fluorescent or Luminescent platforms)
    3. MSD Multiplex Analysis (Mesoscale Electrochemiluminescence platform)
    4. PARP activity and Poly(ADP)-ribose assays
    5. Comet assays
  7. Preclinical Drug Testing
    1. Single or multiple agent cytotoxicity (MTT or DNA content assays)
    2. Multiple agent analysis (Synergy analysis)
    3. Other single or multiple agent assays (e.g., flow cytometry)
  8. Pharmacokinetic assay development
    1. Pharmacokinetic expertise for investigator-initiated early phase studies with planned PK analyses
    2. Sample procurement schedules for pharmacokinetic assays given anticipated or known PK profiles of investigational agents
    3. Design and development of analytical methods
    4. Adoption and validation of established analytical procedures
  9. Pharmacokinetic assay performance
    1. Quantitative measurement of drugs, metabolites, and other small molecules
    2. Pharmacokinetic data analysis

Pharmacology Laboratory Resources

  • Applied Biosystems API 3200 triple quadrupole tandem mass spectrometer coupled with a Shimadzu LC-20 series HPLC system along with SPD-M20A photodiode array/RF-10AxL fluorescence detectors and SIL-20AC refrigerated autosampler
  • Agilent 6540 accurate-mass quadrupole time-of-flight (Q-TOF) mass spectrometer coupled with Agilent 1290 ultra-high performance liquid chromatography (UPLC) system and photodiode array (PDA) detector
  • Equipment for biological sample preparation and storage
  • Computers and data storage devices
  • Software for pharmacokinetic and pharmacodynamic analyses

Fees

Please click here to see fees. (PDF)


Acknowledgement

Remember to acknowledge the valuable services provided by Cancer Center Core Facilities in your research papers and publications:
"This research was supported by the Translational Research Core Facility of the Case Comprehensive Cancer Center (P30 CA43703)."


Contact for Information

Seidman Cancer Center
Director: John J. Pink, PhD
216.368.5420
john.pink@case.edu
Operations Director: Paul Hartman, MS
216.844.1369
phh@case.edu
Manager: Erin Hohler
Seidman Cancer Center, Rm. 3608
216.286.3889/216.368.3890
fax 216.983.0815
emh14@case.edu
Cancer Pharmacology Lab
Co-Director (Pharmacology): Yan Xu, PhD
216.368.0315
Wolstein Research Building
yan.xu@case.edu
Taussig Cancer Institute
Director: Daniel J. Lindner, MD, PhD
216.445.0548
lindned@ccf.org
Manager: Marcella Mance
Taussig Cancer Institute R4-054
216.444.5393
mancem@ccf.org